Skip to main content
. Author manuscript; available in PMC: 2024 Nov 7.
Published in final edited form as: J Shoulder Elbow Surg. 2024 Feb 29;33(6):e308–e321. doi: 10.1016/j.jse.2024.01.028

Table V.

Estimated effects and odds ratios of patient demographic and surgical characteristics on 1-year PENN Shoulder Score (PSS), and 95% confidence intervals for each predictor in the full models in patients undergoing primary shoulder arthroplasty

Variable Level Estimated difference P value

General patient characteristics
 Age 12-yr increase 1.8 (0.27, 3.33) .021
 BMI 7.5-point increase 0.38 (−0.68, 1.44) .485
 CCI 2-unit increase 0.06 (−1.08, 1.20) .915
 Education 4-yr increase 0.22 (−0.84, 1.27) .686
 ADI 35-unit increase −0.34 (−1.85, 1.17) .659
 Baseline VR-12 MCS 16.9-point increase 2.26 (0.56, 3.95) .011
 Sex (vs. Male) Female −2.31 (−4.44, −0.18) .035
 Race (vs. White) Black −3.97 (−9.37, 1.42) .339
Other 1.66 (−5.67, 9.01)
 Smoking status (vs. never) Quit −0.57 (−2.31, 1.17) .01
Current −5.29 (−9.29, −1.29)
 Preoperative opioid use (vs. none in 12 mo) From 12 to 3 mo 0.77 (−1.34, 2.89) .474
Within 3 mo −0.58 (−2.53, 1.36)
 Chronic pain (vs. no) Yes −3.02 (−5.52, −0.53) .019
 Psychiatric diagnosis (vs. no) Yes 0.30 (−1.74, 2.35) .771
 Insurance status (vs. private) Worker's compensation −19.82 (−31.14,-8.49) .005
Medicaid −3.07 (−10.58, 4.43)
Medicare −0.60 (−2.92, 1.71)
 Baseline PSS total 20.9-point increase 1.73 (0.35, 3.10) .014
Disease and surgical characteristics
 Prior shoulder surgery (vs. no) Yes −3.73 (−6.57, −0.89) .01
 Superior-posterior rotator cuff repair (vs. no) Yes 0.25 (−6.56, 7.07) .942
 Glenoid bone loss (vs. no) Yes 2.62 (0.77, 4.47) .006
 Humeral component (vs. uncemented) Cemented −1.19 (−3.69, 1.31) .351
 Diagnosis-arthroplasty (vs. GHOA-rTSA) CTA-rTSA −4.89 (−7.57, −2.21) <.001
GHOA-aTSA 3.34 (1.35, 5.33)

BMI, body mass index; CCI, Charlson Comorbidity Index; ADI, Area Deprivation Index; VR-12 MCS, Veterans RAND 12-Item Health Survey mental component summary; GHOA, glenohumeral osteoarthritis; rTSA, reverse total shoulder arthroplasty; CTA, rotator cuff tear arthropathy; aTSA, primary anatomic total shoulder arthroplasty.

The effects for continuous variables (Age, BMI, Education, ADI, baseline PSS, baseline VR-12 MCS, and CCI) are comparing the quartiles (75th vs. 25th percentiles) indicated in Table II. The false discovery rate for all statistically significant (α = 0.05) potential predictors in this table except sex is controlled at 20% or less by the Benjamini-Yeuketelimethod.1

Examples of interpretation of PSS total scores (identity-link beta regression models):

• CTA-rTSA patients have 1-year PSS total cores that are 4.89 points lower on average respectively than GHOA-rTSA patients, after controlling for all other variables.

• A patient with baseline VR-12 MCS of 60.7 (75th percentile) has 1-year PSS total scores that are 2.26 points higher on average respectively than a patient with baseline VR-12 MCS of 43.9 (25th percentile), after controlling for all other variables.